Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT03647072
PHASE3

PPI Versus Histamine Antagnists as Adjuvant to Chemotherapy

Sponsor: Sherief Abd-Elsalam

View on ClinicalTrials.gov

Summary

The study is a Comparative Clinical and Biochemical Study Evaluating the effect of Proton Pump I nhibitors versus histamine 2 Receptor antagonists as an adjuvant with chemotherapy in patients with Non-hodgkin Lymphoma.

Official title: Comparative Clinical and Biochemical Study Evaluating the Effect of Proton Pump I Nhibitors Versus Histamine 2 Receptor Antagonists as an Adjuvant With Chemotherapy in Patients With Non-hodgkin Lymphoma.

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

60

Start Date

2018-08-01

Completion Date

2027-12

Last Updated

2018-08-27

Healthy Volunteers

No

Conditions

Interventions

DRUG

CHOP

CHOP only

DRUG

CHOP Plus Lanzoprazole

CHOP plus Lanzoprazole 60 mg

DRUG

CHOP Plus Famotidine

CHOP Plus Famotidine 40 mg

Locations (1)

Sherief Abd-Elsalam

Cairo, Egypt